~~<i id='BCFDD91691'><strike id='BCFDD91691'><tt id='BCFDD91691'><pre id='BCFDD91691'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：entertainment 2025-10-01 06:01:39 - browse：9138

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： An innovative path out of biotech’s “valley of death”

leisure time

focus

leisure time

focus

ApersonholdsaWegovyinjectionpen.KayanaSzymczakforSTATMedicareconfirmedthisweekthatitwillcoverNovoNor

WSS

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

U.K. officials, researchers try to ease path for bespoke genetic treatments

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Pregnancy ages women, but effects reverse after delivery

An innovative path out of biotech’s “valley of death”

hotspot

Wikipedia

leisure time

Walensky prepares to leave CDC — and Congress — behind

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Jerome Adams on the need for new antivirals for Covid

Biotech investment managers search for lucrative opportunities

Wildfire smoke exposes gaps in outdoor worker protections

Large hospital system sues Multiplan for low

What does generative AI mean for health care? We asked experts

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

State Dept. review finds Biden bears some blame for Afghanistan failures

Some of the ways extreme heat will change life as we know it

leisure time

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Pharma budget tightening trickles down to Doximity

Diabetes management: Digital health tools fall short, study says

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Timeline: Special counsel's investigation into Trump's handling of classified documents

Surgeons perform first xenotransplant using CRISPR'd pig kidney

focus

focus

leisure time

focus